Distinct role of PLCβ3 in VEGF-mediated directional migration and vascular sprouting

被引:50
作者
Bhattacharya, Resham [1 ]
Kwon, Junhye [1 ]
Li, Xiujuan [2 ]
Wang, Enfeng [1 ]
Patra, Sujata [1 ]
Bida, John Paul [1 ]
Bajzer, Zeljko [1 ]
Claesson-Welsh, Lena [2 ]
Mukhopadhyay, Debabrata [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[2] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden
关键词
Migration; Proliferation; Endothelial signaling; PLC beta 3; ENDOTHELIAL-GROWTH-FACTOR; PHOSPHOLIPASE-C ISOZYMES; PERMEABILITY-FACTOR; CELL-MIGRATION; G-PROTEINS; FACTOR RECEPTOR-2; TUMOR-CELLS; ANGIOGENESIS; PHOSPHORYLATION; ACTIVATION;
D O I
10.1242/jcs.041913
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Endothelial cell proliferation and migration is essential to angiogenesis. Typically, proliferation and chemotaxis of endothelial cells is driven by growth factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). VEGF activates phospholipases (PLCs) specifically PLC gamma 1 - that are important for tubulogenesis, differentiation and DNA synthesis. However, we show here that VEGF, specifically through VEGFR2, induces phosphorylation of two serine residues on PLC beta 3, and this was confirmed in an ex vivo embryoid body model. Knockdown of PLC beta 3 in HUVEC cells affects IP3 production, actin reorganization, migration and proliferation; whereas migration is inhibited, proliferation is enhanced. Our data suggest that enhanced proliferation is precipitated by an accelerated cell cycle, and decreased migration by an inability to activate CDC42. Given that PLC beta 3 is typically known as an effector of heterotrimeric G-proteins, our data demonstrate a unique crosstalk between the G-protein and receptor tyrosine kinase (RTK) axes and reveal a novel molecular mechanism of VEGF signaling and, thus, angiogenesis.
引用
收藏
页码:1025 / 1034
页数:10
相关论文
共 51 条
[1]   Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro [J].
Amerongen, GPV ;
Koolwijk, P ;
Versteilen, A ;
van Hinsbergh, VWM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :211-217
[2]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[3]  
BROCK TA, 1991, AM J PATHOL, V138, P213
[4]   Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1 [J].
Cascone, I ;
Audero, E ;
Giraudo, E ;
Napione, L ;
Maniero, F ;
Philips, MR ;
Collard, JG ;
Serini, G ;
Bussolino, F .
BLOOD, 2003, 102 (07) :2482-2490
[5]  
COCKCROFT S, 1992, BIOCHEM J, V288, P1
[6]  
DVORAK HF, 1979, JNCI-J NATL CANCER I, V62, P1459
[7]   VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia [J].
Gerhardt, H ;
Golding, M ;
Fruttiger, M ;
Ruhrberg, C ;
Lundkvist, A ;
Abramsson, A ;
Jeltsch, M ;
Mitchell, C ;
Alitalo, K ;
Shima, D ;
Betsholtz, C .
JOURNAL OF CELL BIOLOGY, 2003, 161 (06) :1163-1177
[8]   Phosphorylation of IQGAP1 modulates its binding to Cdc42, revealing a new type of Rho-GTPase regulator [J].
Grohmanova, K ;
Schlaepfer, D ;
Hess, D ;
Gutierrez, P ;
Beck, M ;
Kroschewski, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48495-48504
[9]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) EXPRESSION AND ANGIOGENESIS IN CERVICAL NEOPLASIA [J].
GUIDI, AJ ;
ABUJAWDEH, G ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
DVORAK, HF ;
BROWN, LF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (16) :1237-1245
[10]   IDENTIFICATION AND CHARACTERIZATION OF A OUABAIN-LIKE COMPOUND FROM HUMAN PLASMA [J].
HAMLYN, JM ;
BLAUSTEIN, MP ;
BOVA, S ;
DUCHARME, DW ;
HARRIS, DW ;
MANDEL, F ;
MATHEWS, WR ;
LUDENS, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6259-6263